TG Therapeutics, Inc. (Nasdaq : TGTX) announced that it has filed with the FDA an amended protocol for the GENUINE ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE